GB201415367D0 - Methods for detecting abnormalities in haemoglobin - Google Patents

Methods for detecting abnormalities in haemoglobin

Info

Publication number
GB201415367D0
GB201415367D0 GBGB1415367.0A GB201415367A GB201415367D0 GB 201415367 D0 GB201415367 D0 GB 201415367D0 GB 201415367 A GB201415367 A GB 201415367A GB 201415367 D0 GB201415367 D0 GB 201415367D0
Authority
GB
United Kingdom
Prior art keywords
haemoglobin
methods
detecting abnormalities
abnormalities
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1415367.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILES RAYMOND K AND DOCHERTY SUZANNE M E AND ABBAN THOMAS AND NAASE MAHMOUD AND ILES JASON K
Original Assignee
ILES RAYMOND K AND DOCHERTY SUZANNE M E AND ABBAN THOMAS AND NAASE MAHMOUD AND ILES JASON K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILES RAYMOND K AND DOCHERTY SUZANNE M E AND ABBAN THOMAS AND NAASE MAHMOUD AND ILES JASON K filed Critical ILES RAYMOND K AND DOCHERTY SUZANNE M E AND ABBAN THOMAS AND NAASE MAHMOUD AND ILES JASON K
Priority to GBGB1415367.0A priority Critical patent/GB201415367D0/en
Publication of GB201415367D0 publication Critical patent/GB201415367D0/en
Priority to CN201580059324.5A priority patent/CN107110873B/zh
Priority to DK15760235.0T priority patent/DK3186640T3/da
Priority to US15/506,730 priority patent/US10359431B2/en
Priority to PT157602350T priority patent/PT3186640T/pt
Priority to PCT/GB2015/052491 priority patent/WO2016030688A1/en
Priority to EP15760235.0A priority patent/EP3186640B1/en
Priority to JP2017511663A priority patent/JP2017525971A/ja
Priority to ES15760235T priority patent/ES2751480T3/es
Priority to CY20191101062T priority patent/CY1122239T1/el
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
GBGB1415367.0A 2014-08-29 2014-08-29 Methods for detecting abnormalities in haemoglobin Ceased GB201415367D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1415367.0A GB201415367D0 (en) 2014-08-29 2014-08-29 Methods for detecting abnormalities in haemoglobin
ES15760235T ES2751480T3 (es) 2014-08-29 2015-08-27 Procedimiento para la detección de anormalidades en hemoglobina
PT157602350T PT3186640T (pt) 2014-08-29 2015-08-27 Método para deteção de anomalias em hemoglobina
DK15760235.0T DK3186640T3 (da) 2014-08-29 2015-08-27 Fremgangsmåde til påvisning af anomalier i hæmoglobin
US15/506,730 US10359431B2 (en) 2014-08-29 2015-08-27 Method for detecting abnormalities in hemoglobin
CN201580059324.5A CN107110873B (zh) 2014-08-29 2015-08-27 检测血红蛋白中异常的方法
PCT/GB2015/052491 WO2016030688A1 (en) 2014-08-29 2015-08-27 Method for detecting abnormalities in hemoglobin
EP15760235.0A EP3186640B1 (en) 2014-08-29 2015-08-27 Method for detecting abnormalities in hemoglobin
JP2017511663A JP2017525971A (ja) 2014-08-29 2015-08-27 ヘモグロビンにおける異常を検出する方法
CY20191101062T CY1122239T1 (el) 2014-08-29 2019-10-10 Μεθοδος για την ανιχνευση ανωμαλιων στην αιμοσφαιρινη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1415367.0A GB201415367D0 (en) 2014-08-29 2014-08-29 Methods for detecting abnormalities in haemoglobin

Publications (1)

Publication Number Publication Date
GB201415367D0 true GB201415367D0 (en) 2014-10-15

Family

ID=51752371

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1415367.0A Ceased GB201415367D0 (en) 2014-08-29 2014-08-29 Methods for detecting abnormalities in haemoglobin

Country Status (10)

Country Link
US (1) US10359431B2 (enExample)
EP (1) EP3186640B1 (enExample)
JP (1) JP2017525971A (enExample)
CN (1) CN107110873B (enExample)
CY (1) CY1122239T1 (enExample)
DK (1) DK3186640T3 (enExample)
ES (1) ES2751480T3 (enExample)
GB (1) GB201415367D0 (enExample)
PT (1) PT3186640T (enExample)
WO (1) WO2016030688A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3555631A4 (en) * 2016-12-19 2020-08-12 The UAB Research Foundation MASS SPECTROMETRY STANDARDS FOR HEMOGLOBIN BETA AND HEMOGLOBIN BETA SICKLE CELL DISEASE AND THEIR USES
WO2019022189A1 (ja) * 2017-07-27 2019-01-31 国立大学法人九州大学 グロビンタイピングペプチド
CN108062977A (zh) * 2017-12-18 2018-05-22 广东祥岳生物技术有限公司 一种新生儿地中海贫血筛查结果自动判断系统
CN110658252A (zh) * 2019-10-01 2020-01-07 长沙湘华质谱医学科技有限公司 用于质谱诊断地中海贫血症的特征蛋白质谱模型及其用途
CN110658251A (zh) * 2019-10-01 2020-01-07 长沙湘华质谱医学科技有限公司 表征地中海贫血症的特征蛋白组合物或质谱模型的用途
CN110632326A (zh) * 2019-10-01 2019-12-31 北京毅新博创生物科技有限公司 用于质谱诊断地中海贫血症的特征蛋白标记组合物及其诊断产品
CN111638261B (zh) * 2020-04-17 2023-04-07 融智生物科技（青岛）有限公司 一种计算设备、存储介质和地中海贫血筛查装置及系统
CN111948404B (zh) * 2020-08-03 2023-04-07 融智生物科技（青岛）有限公司 用于筛查地中海贫血的特征蛋白标记组合物、质谱模型及其应用
CN116203143B (zh) * 2022-05-11 2024-01-05 重庆医科大学附属儿童医院 血红蛋白病的标志物组合物及其筛查试剂与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492095A (en) * 1967-10-05 1970-01-27 Harold B Tillen Product for and method of testing blood for the presence of hemoglobin s
US4847209A (en) 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
FR2821428B1 (fr) * 2001-02-23 2004-08-06 Abx Sa Reactif et procede pour l'identification et le comptage de cellules biologiques
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
US20040171026A1 (en) 2001-09-05 2004-09-02 Hochstrasser Denis Francois Diagnostic method for transmissible spongiform encephalopathies
FI20031370A0 (fi) * 2003-09-23 2003-09-23 Wallac Oy Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
EP1533617A1 (en) * 2003-11-19 2005-05-25 RMF Dictagene S.A. Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
WO2005116607A1 (en) * 2004-05-27 2005-12-08 Monash University A method for the rapid analysis of polypeptides
GB0502068D0 (en) * 2005-02-01 2005-03-09 King S College London Screening method
WO2007117794A2 (en) 2006-03-06 2007-10-18 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycated peptides and methods of use
JP2007263896A (ja) * 2006-03-29 2007-10-11 Univ Nagoya 肺癌患者の術後予後予測のための生物マーカー及びその方法
WO2008011158A2 (en) * 2006-07-21 2008-01-24 Amgen Inc. Method of detecting and/ or measuring hepcidin in a sample
US7951776B2 (en) 2006-09-01 2011-05-31 American Type Culture Collection Methods for treatment of type 1 diabetes
US9250248B2 (en) 2006-11-01 2016-02-02 The Johns Hopkins University Early detection of diabetes
JP2011515680A (ja) 2008-03-17 2011-05-19 ネルソン，ランドール，ダブリュ． 糖尿病のためのバイオマーカーおよびアッセイ
WO2009144229A1 (en) 2008-05-27 2009-12-03 F. Hoffmann-La Roche Ag Method for risk reduction in glycemic control
CA2765457A1 (en) 2009-07-07 2011-01-13 Uvic Industry Partnerships Inc. Methods for early detection of blood disorders
SG195180A1 (en) * 2011-05-31 2013-12-30 Singapore Health Serv Pte Ltd Method for detecting disease biomarkers
CN103278574B (zh) * 2013-04-26 2014-12-10 首都医科大学附属北京朝阳医院 利用液相色谱串联三重四级杆质谱仪检测糖化血红蛋白的方法

Also Published As

Publication number Publication date
DK3186640T3 (da) 2019-10-21
CN107110873B (zh) 2019-07-05
EP3186640A1 (en) 2017-07-05
ES2751480T3 (es) 2020-03-31
US20180224462A1 (en) 2018-08-09
JP2017525971A (ja) 2017-09-07
US10359431B2 (en) 2019-07-23
WO2016030688A1 (en) 2016-03-03
CN107110873A (zh) 2017-08-29
EP3186640B1 (en) 2019-07-24
PT3186640T (pt) 2019-10-30
CY1122239T1 (el) 2020-11-25

Similar Documents

Publication Publication Date Title
GB201415367D0 (en) Methods for detecting abnormalities in haemoglobin
GB201408100D0 (en) Detection method
PT3314010T (pt) Processo para deteção de aberrações cromossómicas
GB2556964B (en) Improvements in watermarking
PL3398449T3 (pl) Sposób smoltyfikacji u łososiowatych
GB201420756D0 (en) Improvements in tissue processing
GB201405203D0 (en) Detecting apparatus
PL3223882T3 (pl) Urządzenie do dializy
GB201416459D0 (en) Detection method
GB201411072D0 (en) Stress monitoring for individuals in moving structures
GB2532079B (en) Improvements in watermarking
GB201419330D0 (en) Detection method
GB201403115D0 (en) Red blood cell detection
GB201523035D0 (en) In terferometry
GB2532081B (en) Improvements in watermarking
GB2532082B (en) Improvements in watermarking
PL3177727T3 (pl) Sposoby odwadniania w procesach fermentacyjnych
GB2540723B (en) Improvements in watermarking
GB201415791D0 (en) Improvements in frying technology
GB201419978D0 (en) Improvements in watermarking
GB201419987D0 (en) Improvements in watermarking
GB201419979D0 (en) Improvements in watermarking
GB201411261D0 (en) Improvements in underwater connections
GB201402174D0 (en) Detection method
GB2534645B (en) Improvements in watermarking

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)